Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry
Heber Victor Tolomeu, Carlos Alberto Manssour Fraga
Molecules (2023) Vol. 28, Iss. 2, pp. 838-838
Open Access | Times Cited: 73
Antibacterial, antifungal, anti‐inflammatory evaluation, molecular docking, and density functional theory exploration of 2‐(1H‐benzimidazol‐2‐yl)guanidine mixed‐ligand complexes: Synthesis and characterization
Hany M. Abd El‐Lateef, Mai M. Khalaf, Amer A. Amer, et al.
Applied Organometallic Chemistry (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 35
One-pot synthesis of novel poly-substituted 3-cyanopyridines: Molecular docking, antimicrobial, cytotoxicity, and DFT/TD-DFT studies
Islam M. Abdellah, Mohamed R. Eletmany, Antar A. Abdelhamid, et al.
Journal of Molecular Structure (2023) Vol. 1289, pp. 135864-135864
Closed Access | Times Cited: 21
Novel guanidine derivatives targeting leukemia as selective Src/Abl dual inhibitors: Design, synthesis and anti-proliferative activity
Amr H. Moustafa, Asmaa M. AboulMagd, Ali M. Ali, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107410-107410
Closed Access | Times Cited: 11
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies
Bahaa G. M. Youssif, Martha M. Morcoss, Stefan Bräse, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 446-446
Open Access | Times Cited: 8
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access
A comprehensive review of recent advances in the biological activities of 1,2,4‐oxadiazoles
Omnia M. Hendawy
Archiv der Pharmazie (2022) Vol. 355, Iss. 7
Closed Access | Times Cited: 23
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3- (2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFR WT/ EGFR T790M inhibitors
Lamya H. Al-Wahaibi, Anber F. Mohammed, Fatema El-Zahraa S. Abdel Rahman, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 11
Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAFV600E
Samar El‐Kalyoubi, Hesham A. M. Gomaa, Elshimaa M. N. Abdelhafez, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 716-716
Open Access | Times Cited: 10
Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 3
New Potential Agents for Malignant Melanoma Treatment—Most Recent Studies 2020–2022
Paweł Kozyra, Danuta Krasowska, Monika Pitucha
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6084-6084
Open Access | Times Cited: 16
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation
Firas Obaid Arhema Frejat, Hongjin Zhai, Yaquan Cao, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105922-105922
Closed Access | Times Cited: 12
Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAFV600E Dual Inhibitors Endowed with Antiproliferative Activity
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Alaa A. Hassan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 7
New 1,3,4‐oxadiazole‐chalcone/benzimidazole hybrids as potent antiproliferative agents
Fatma Fouad Hagar, Samar H. Abbas, Dalia Abdelhamid, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 2
Closed Access | Times Cited: 11
Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1H)-ones as Multi-Target Inhibitors
Essmat M. El‐Sheref, Stefan Bräse, Hendawy N. Tawfeek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13300-13300
Open Access | Times Cited: 6
Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E
Fatma Fouad Hagar, Samar H. Abbas, Hesham A. M. Gomaa, et al.
BMC Chemistry (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Design, synthesis, and modelling study of new 1,2,3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors
Mohamed T.‐E. Maghraby, Ola I. A. Salem, Bahaa G. M. Youssif, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 3, pp. 749-759
Closed Access | Times Cited: 10
New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity
Mohamed T.‐E. Maghraby, Tahani Mazyad Almutairi, Stefan Bräse, et al.
Molecules (2023) Vol. 28, Iss. 20, pp. 7092-7092
Open Access | Times Cited: 5
Design and synthesis of new quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Hesham A. Abou‐Zied, et al.
Journal of Molecular Structure (2023) Vol. 1297, pp. 136953-136953
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top